top of page

Latest News

Oct 8, 2024

Cognitact hosted the "Decoding Dementia" public health talk, focusing on cutting-edge detection tools and latest treatment breakthroughs in Alzheimer’s disease

Sep 25, 2024

Cognitact sponsored the CME lunch symposium hosted by the Association of Private Medical Specialists of Hong Kong

Jul 9, 2024

Cognitact was invited to the "Early Detection, Early Treatment" public seminar by Yan Oi Tong Clarea Au Eldergarten

Mar 21, 2024

Cognitact won the "Most Outstanding Enterprise of the Year" by the Hong Kong Commercial Times Business Awards 2024

Nov 1, 2023

Cognitact won the "Smart People Grand & Gold (Smart Ageing) Awards" at Hong Kong ICT Awards 2023

Nov 7, 2023

Cognitact attended the 36th Annual Scientific Meeting of the Hong Kong Neurological Society

Oct 18, 2023

Cognitact received 4 million $USD Series A+ funding from Qiming Venture Partners

Sep 1, 2023

Cognitact's technology was featured in BioSpectrum, Asia Edition

Jul 17, 2023

Cognitact launched PlasmarkAD® blood test for early detection of Alzheimer's Disease

Jun 28, 2023

Cognitact won the "Asia International Innovation & Invention Gold Award".

Jun 19, 2023

Cognitact attended the Annual Scientific Meeting of the Hong Kong Geriatrics Society

May 29, 2023

Cognitact won the Technology Start-up Support Scheme for Universities (TSSSU+) grant by Hong Kong Innovation and Technology Commission

May 17, 2023

Cognitact presented at the Hong Kong International Medical and Healthcare Exhibition by the Hong Kong Trade Development Council

May 5, 2023

Cognitact won the "Chinese Delegation Invention and Innovation Excellence Award" and "Jury Commendation Gold Award" at the 48th International Exhibition of Inventions Geneva 2023

Aug 11, 2022

Cognitact received 5 million $USD Series A funding from lead investor New World Development Company Limited and co-investor Great Eagle Holdings Limited

Dec 27, 2021

文匯報專題– 滴血知腦疾，新招驗腦退化

bottom of page